Category: Uncategorized

Pharma Life Cycle Analysis – Why It Is Important

Despite numerous and efficacious therapies and treatments being readily available in the pharmaceutical supply chain, there has been for some time a critical need for new drugs, especially since viral strain outbreaks from the COVID-19...

Read More »

i3 Consult Guest Presenter at Bionabu Growth Labs

i3 Consult is proud to announce that it presented its company profile at the Bionabu Growth Labs event hosted last month Tuesday 25th January. The event has been reviewed as a great success and in...

Read More »

Launch of Our i3 QoW Page

i3 Consult is proud to announce the launch of its i3 QoW Web page - https://www.i3consult.com/quote-of-the-week/. This Web content is based on an extraordinary collection of more than a year of Quotes of the Week (QoW)...

Read More »

iClinical: Data platform for virtual clinical trials

As part of i3 Consult’s partnership with iClinical, we are pleased to announce the launch of iClinical’s Data Platform for Virtual Clinical Trials mobile app. This technology is destined to leverage clinical trial management and...

Read More »

Changes to our website www.i3Consult.com

Hi there, i3 Consult is proud to announce the launch of new content for www.i3consult.com. As shown on our i3 Services page, this launch is to reflect our new service offer of greater niche consultancy solutions for  “4Ps” sectors...

Read More »

iClinical and i3 Consult Partnership Announcement

Hi there, We are pleased to announce i3 Consult is partnering with iClinical to support our services in clinical trial management. iClinical provides a customised mobile/cloud data platform to collect and analyse clinical trial data...

Read More »

Pharmacovigilance : Challenges & Opportunities

The competitiveness of drug development has been the impetus for new and accelerated regulatory pathways. While the growing patient-centric healthcare market coupled with a vested interest in safety information from a range of governmental and...

Read More »

The Drivers and Barriers to Growth in the CRO Industry

Biotechnology R and D spending reached $45.7 billion by FY2016, this represented a 12% increase from the previous financial year. This was the seventh consecutive year that biotech companies increased their cumulative R&D spending and...

Read More »